4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-001526
Chief Medical Officer sold 2,034 shares at an average $36.30 ($73,831)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yeramian Patrick D Chief Medical Officer | 2023-01-06 | Sale | +1,405 | $36.08 | $50,691 | 204,928 | D |
| Yeramian Patrick D Chief Medical Officer | 2023-01-06 | Sale | +629 | $36.79 | $23,140 | 204,299 | D |
| Open-market sales · 2,034 sh · avg $36.30 · $73,831 | |||||||
Loading xslF345X03/doc4.xml…